Literature DB >> 26429353

suPAR: A Cardiac Biomarker With a Future?

Yaron Arbel1, Bradley H Strauss2.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26429353     DOI： 10.1016/j.cjca.2015.08.011

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN： 0828-282X            Impact factor:   5.223


× No keyword cloud information.
  4 in total

1.  Soluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis.

Authors:  Christiane Drechsler; Salim S Hayek; Changli Wei; Sanja Sever; Bernd Genser; Vera Krane; Andreas Meinitzer; Winfried März; Christoph Wanner; Jochen Reiser
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-11       Impact factor: 8.237

2.  Soluble Urokinase-type Plasminogen Activator Receptor Predicts All-cause 5-Year Mortality in Ischemic Stroke and TIA.

Authors:  Juha Onatsu; Mikko Taina; Pirjo Mustonen; Marja Hedman; Antti Muuronen; Otso Arponen; Miika Korhonen; Pekka Jäkälä; Ritva Vanninen; Kari Pulkki
Journal:  In Vivo       Date:  2017 May-Jun       Impact factor: 2.155

3.  Soluble urokinase plasminogen activation receptor and long-term outcomes in persons undergoing coronary angiography.

Authors:  Claudia Sommerer; Martin Zeier; Christian Morath; Jochen Reiser; Hubert Scharnagl; Tatjana Stojakovic; Graciela E Delgado; Winfried März; Marcus E Kleber
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

4.  Predicting Mortality in African Americans With Type 2 Diabetes Mellitus: Soluble Urokinase Plasminogen Activator Receptor, Coronary Artery Calcium, and High-Sensitivity C-Reactive Protein.

Authors:  Salim S Hayek; Jasmin Divers; Mohamad Raad; Jianzhao Xu; Donald W Bowden; Melissa Tracy; Jochen Reiser; Barry I Freedman
Journal:  J Am Heart Assoc       Date:  2018-05-01       Impact factor: 5.501
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.